- Hong Kong
- /
- Healthcare Services
- /
- SEHK:928
Life Healthcare Group First Half 2024 Earnings: EPS: HK$0.001 (vs HK$0.001 loss in 1H 2023)
Life Healthcare Group (HKG:928) First Half 2024 Results
Key Financial Results
- Revenue: HK$83.4m (up 48% from 1H 2023).
- Net income: HK$1.69m (up from HK$1.26m loss in 1H 2023).
- Profit margin: 2.0% (up from net loss in 1H 2023). The move to profitability was driven by higher revenue.
- EPS: HK$0.001 (up from HK$0.001 loss in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Life Healthcare Group shares are up 4.3% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Life Healthcare Group (at least 1 which is a bit unpleasant), and understanding them should be part of your investment process.
Valuation is complex, but we're here to simplify it.
Discover if King International Investment might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:928
King International Investment
An investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong.
Adequate balance sheet low.
Market Insights
Community Narratives

